Theravance Biopharma is a biopharmaceutical company focused on developing innovative medicines for serious respiratory diseases, like chronic obstructive pulmonary disease (COPD) and asthma. Its therapies, including Yupelri, target specific receptors to improve breathing and patient outcomes. Healthcare providers and patients with respiratory conditions benefit from these specialized treatments, which offer new options for managing chronic lung diseases.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends